Modern Healthspan The Future Of Mitochondria-Derived Peptides - Prof Pinchas Cohen Ep6
In this video Dr Cohen talks CohBar, a company that he co-founded with Professor Nir Barzilai and some of the work they are doing, as well as the latest developments in his lab. He also discusses the need for precision medicine in addressing diseases of aging.
Mitochondrial DNA variation in Alzheimer’s disease reveals a unique microprotein called SHMOOSE
https://www.nature.com/articles/s41380-022-01769-3
Professor Pinchas Cohen is the dean of the USC Leonard Davis School of Gerontology. He is a pioneer in the emerging science of mitochondria-derived peptides and their possible therapeutic benefits for diabetes, Alzheimer's and other diseases of aging, an area which remains the focus of his current research.
Mitochondria-derived peptides in aging and healthspan
https://pubmed.ncbi.nlm.nih.gov/35499074/
Dr Cohen's page at USC
https://gero.usc.edu/faculty/cohen/
The Cohen Lab
https://gero.usc.edu/labs/cohenlab/
CohBar Inc. Web site